• Invest-NL published a market analysis arguing the Netherlands can strengthen its biotech position by linking more tightly with high-tech industries.
• The report flags measurement, data analysis, automation, process development, production capacity as key constraints on scaling biotech beyond the lab.
• It identifies investable “enabling” technologies aligned with Dutch strengths in precision engineering, photonics, semiconductor equipment, systems integration.
• The analysis calls for shared national infrastructure for experimentation, measurement, process development, scale-up to shorten timelines, reduce fragmentation across startups.
• The deep dive launches a four-part biotech series that will map investment opportunities, scale-up barriers, solutions across agrifood, health, industrial biotech.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invest-NL NV published the original content used to generate this news brief on September 18, 2026, and is solely responsible for the information contained therein.